View in EDS PDF Full Text

A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C.

Saved in:
Bibliographic Details
Title: A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C.
Authors: You BC; Department of Internal Medicine, Soon Chun Hyang University Bucheon Hospital, Soon Chun Hyang University College of Medicine, Bucheon, Korea., Kim YS, Kim Hi, Kim SH, Park SS, Seo YR, Kim SG, Lee SW, Kim HS, Jeong SW, Jang JY, Kim BS
Source: Clinical and molecular hepatology [Clin Mol Hepatol] 2012 Sep; Vol. 18 (3), pp. 272-8. Date of Electronic Publication: 2012 Sep 25.
Publication Type: Journal Article
Journal Info: Publisher: Korean Association for the Study of the Liver Country of Publication: Korea (South) NLM ID: 101586730 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2287-285X (Electronic) Linking ISSN: 22872728 NLM ISO Abbreviation: Clin Mol Hepatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 23091807
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22You+BC%22">You BC</searchLink>; Department of Internal Medicine, Soon Chun Hyang University Bucheon Hospital, Soon Chun Hyang University College of Medicine, Bucheon, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+YS%22">Kim YS</searchLink><br /><searchLink fieldCode="AU" term="%22Kim+Hi%22">Kim Hi</searchLink><br /><searchLink fieldCode="AU" term="%22Kim+SH%22">Kim SH</searchLink><br /><searchLink fieldCode="AU" term="%22Park+SS%22">Park SS</searchLink><br /><searchLink fieldCode="AU" term="%22Seo+YR%22">Seo YR</searchLink><br /><searchLink fieldCode="AU" term="%22Kim+SG%22">Kim SG</searchLink><br /><searchLink fieldCode="AU" term="%22Lee+SW%22">Lee SW</searchLink><br /><searchLink fieldCode="AU" term="%22Kim+HS%22">Kim HS</searchLink><br /><searchLink fieldCode="AU" term="%22Jeong+SW%22">Jeong SW</searchLink><br /><searchLink fieldCode="AU" term="%22Jang+JY%22">Jang JY</searchLink><br /><searchLink fieldCode="AU" term="%22Kim+BS%22">Kim BS</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101586730%22">Clinical and molecular hepatology</searchLink> [Clin Mol Hepatol] 2012 Sep; Vol. 18 (3), pp. 272-8. <i>Date of Electronic Publication: </i>2012 Sep 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Korean+Association+for+the+Study+of+the+Liver%22">Korean Association for the Study of the Liver </searchLink><i>Country of Publication: </i>Korea (South) <i>NLM ID: </i>101586730 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2287-285X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222872728%22">22872728 </searchLink><i>NLM ISO Abbreviation: </i>Clin Mol Hepatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23091807
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3350/cmh.2012.18.3.272
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 272
    Titles:
      – TitleFull: A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: You BC
      – PersonEntity:
          Name:
            NameFull: Kim YS
      – PersonEntity:
          Name:
            NameFull: Kim Hi
      – PersonEntity:
          Name:
            NameFull: Kim SH
      – PersonEntity:
          Name:
            NameFull: Park SS
      – PersonEntity:
          Name:
            NameFull: Seo YR
      – PersonEntity:
          Name:
            NameFull: Kim SG
      – PersonEntity:
          Name:
            NameFull: Lee SW
      – PersonEntity:
          Name:
            NameFull: Kim HS
      – PersonEntity:
          Name:
            NameFull: Jeong SW
      – PersonEntity:
          Name:
            NameFull: Jang JY
      – PersonEntity:
          Name:
            NameFull: Kim BS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2012 Sep
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-electronic
              Value: 2287-285X
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Clinical and molecular hepatology
              Type: main
ResultId 1